Table I.
Univariate analysis for recurrence within 5 years in relation to predictive factors.
| Variable | Relapse | Non-relapse | χ2 | P-value |
|---|---|---|---|---|
| Age (years) | ||||
| <50 | 30 | 45 | 0.229 | 0.633 |
| ≥50 | 20 | 25 | ||
| Clinical stage | ||||
| I–II | 25 | 53 | 8.477 | 0.004 |
| III–IV | 25 | 17 | ||
| ER status | ||||
| Negative | 30 | 28 | 4.672 | 0.031 |
| Positive | 20 | 42 | ||
| PR status | ||||
| Negative | 29 | 30 | 2.676 | 0.102 |
| Positive | 21 | 40 | ||
| HER2 status | ||||
| Negative | 28 | 29 | 2.483 | 0.115 |
| Positive | 22 | 41 | ||
| MTMR3 expression | ||||
| Low | 8 | 23 | 4.326 | 0.038 |
| High | 42 | 47 |
Significant P-values are denoted in bold font. ER, estrogen receptor; PR, progesterone receptor; HER2, erb-b2 receptor tyrosine kinase 2; MTMR3, myotubularin related protein 3.